Cargando…

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma

BACKGROUND: Hyaluronan accumulation correlates with the degree of malignancy in many solid tumor types, including malignant endometrial carcinomas. To elucidate the mechanism of hyaluronan accumulation, we examined the expression levels of the hyaluronan synthases (HAS1, HAS2 and HAS3) and hyaluroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Nykopp, Timo K, Rilla, Kirsi, Tammi, Markku I, Tammi, Raija H, Sironen, Reijo, Hämäläinen, Kirsi, Kosma, Veli-Matti, Heinonen, Seppo, Anttila, Maarit
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956733/
https://www.ncbi.nlm.nih.gov/pubmed/20875124
http://dx.doi.org/10.1186/1471-2407-10-512
_version_ 1782188185793593344
author Nykopp, Timo K
Rilla, Kirsi
Tammi, Markku I
Tammi, Raija H
Sironen, Reijo
Hämäläinen, Kirsi
Kosma, Veli-Matti
Heinonen, Seppo
Anttila, Maarit
author_facet Nykopp, Timo K
Rilla, Kirsi
Tammi, Markku I
Tammi, Raija H
Sironen, Reijo
Hämäläinen, Kirsi
Kosma, Veli-Matti
Heinonen, Seppo
Anttila, Maarit
author_sort Nykopp, Timo K
collection PubMed
description BACKGROUND: Hyaluronan accumulation correlates with the degree of malignancy in many solid tumor types, including malignant endometrial carcinomas. To elucidate the mechanism of hyaluronan accumulation, we examined the expression levels of the hyaluronan synthases (HAS1, HAS2 and HAS3) and hyaluronidases (HYAL1 and HYAL2), and correlated them with hyaluronan content and HAS1-3 immunoreactivity. METHODS: A total of 35 endometrial tissue biopsies from 35 patients, including proliferative and secretory endometrium (n = 10), post-menopausal proliferative endometrium (n = 5), complex atypical hyperplasia (n = 4), grade 1 (n = 8) and grade 2 + 3 (n = 8) endometrioid adenocarcinomas were divided for gene expression by real-time RT-PCR, and paraffin embedded blocks for hyaluronan and HAS1-3 cytochemistry. RESULTS: The mRNA levels of HAS1-3 were not consistently changed, while the immunoreactivity of all HAS proteins was increased in the cancer epithelium. Interestingly, HAS3 mRNA, but not HAS3 immunoreactivity, was increased in post-menopausal endometrium compared to normal endometrium (p = 0.003). The median of HYAL1 mRNA was 10-fold and 15-fold lower in both grade 1 and grade 2+3 endometrioid endometrial cancers, as compared to normal endometrium (p = 0.004-0.006), and post-menopausal endometrium (p = 0.002), respectively. HYAL2 mRNA was also reduced in cancer (p = 0.02) and correlated with HYAL1 (r = 0.8, p = 0.0001). There was an inverse correlation between HYAL1 mRNA and the epithelial hyaluronan staining intensity (r = -0.6; P = 0.001). CONCLUSION: The results indicated that HYAL1 and HYAL2 were coexpressed and significantly downregulated in endometrioid endometrial cancer and correlated with the accumulation of hyaluronan. While immunoreactivity for HASs increased in the cancer cells, tumor mRNA levels for HASs were not changed, suggesting that reduced turnover of HAS protein may also have contributed to the accumulation of hyaluronan.
format Text
id pubmed-2956733
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29567332010-10-19 Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma Nykopp, Timo K Rilla, Kirsi Tammi, Markku I Tammi, Raija H Sironen, Reijo Hämäläinen, Kirsi Kosma, Veli-Matti Heinonen, Seppo Anttila, Maarit BMC Cancer Research Article BACKGROUND: Hyaluronan accumulation correlates with the degree of malignancy in many solid tumor types, including malignant endometrial carcinomas. To elucidate the mechanism of hyaluronan accumulation, we examined the expression levels of the hyaluronan synthases (HAS1, HAS2 and HAS3) and hyaluronidases (HYAL1 and HYAL2), and correlated them with hyaluronan content and HAS1-3 immunoreactivity. METHODS: A total of 35 endometrial tissue biopsies from 35 patients, including proliferative and secretory endometrium (n = 10), post-menopausal proliferative endometrium (n = 5), complex atypical hyperplasia (n = 4), grade 1 (n = 8) and grade 2 + 3 (n = 8) endometrioid adenocarcinomas were divided for gene expression by real-time RT-PCR, and paraffin embedded blocks for hyaluronan and HAS1-3 cytochemistry. RESULTS: The mRNA levels of HAS1-3 were not consistently changed, while the immunoreactivity of all HAS proteins was increased in the cancer epithelium. Interestingly, HAS3 mRNA, but not HAS3 immunoreactivity, was increased in post-menopausal endometrium compared to normal endometrium (p = 0.003). The median of HYAL1 mRNA was 10-fold and 15-fold lower in both grade 1 and grade 2+3 endometrioid endometrial cancers, as compared to normal endometrium (p = 0.004-0.006), and post-menopausal endometrium (p = 0.002), respectively. HYAL2 mRNA was also reduced in cancer (p = 0.02) and correlated with HYAL1 (r = 0.8, p = 0.0001). There was an inverse correlation between HYAL1 mRNA and the epithelial hyaluronan staining intensity (r = -0.6; P = 0.001). CONCLUSION: The results indicated that HYAL1 and HYAL2 were coexpressed and significantly downregulated in endometrioid endometrial cancer and correlated with the accumulation of hyaluronan. While immunoreactivity for HASs increased in the cancer cells, tumor mRNA levels for HASs were not changed, suggesting that reduced turnover of HAS protein may also have contributed to the accumulation of hyaluronan. BioMed Central 2010-09-27 /pmc/articles/PMC2956733/ /pubmed/20875124 http://dx.doi.org/10.1186/1471-2407-10-512 Text en Copyright ©2010 Nykopp et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nykopp, Timo K
Rilla, Kirsi
Tammi, Markku I
Tammi, Raija H
Sironen, Reijo
Hämäläinen, Kirsi
Kosma, Veli-Matti
Heinonen, Seppo
Anttila, Maarit
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
title Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
title_full Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
title_fullStr Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
title_full_unstemmed Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
title_short Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
title_sort hyaluronan synthases (has1-3) and hyaluronidases (hyal1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956733/
https://www.ncbi.nlm.nih.gov/pubmed/20875124
http://dx.doi.org/10.1186/1471-2407-10-512
work_keys_str_mv AT nykopptimok hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT rillakirsi hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT tammimarkkui hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT tammiraijah hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT sironenreijo hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT hamalainenkirsi hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT kosmavelimatti hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT heinonenseppo hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma
AT anttilamaarit hyaluronansynthaseshas13andhyaluronidaseshyal12intheaccumulationofhyaluronaninendometrioidendometrialcarcinoma